Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Playing the Big Cannabis Rebound

Regal Consulting, Regal Consulting
0 Comments| February 5, 2019

{{labelSign}}  Favorites
{{errorMessage}}

HENDERSON, NV February 5, 2019 / Cannabis stocks, as measured by the Global Cannabis Stock Index, bounced back from Q4 losses of 44.2%, rallying 44.2% in January, the second-best month in history for canna stocks pricewise. This trend looks to continue, we've highlighted some of the best opportunities for cannabis investors.

One we think has explosive growth potential is Real Brands, Inc. (RLBD).The companyis launching a CBD beverage called Omega Hemp™ Water. RLBD has strong management with a solid background in branding and the beverage industry and plans to expand their holdings focusing on at least three CBD Categories: smokables, edibles and topical balms and lotions. The time to research on RLBD is now; the company just announced it acquired the trademarks: Humboldt Brands®, Hemp-Aid® and HempAid®. This could be a sign of more news to come.

Today we are highlighting:Real Brands, Inc. (RLBD), Aurora Cannabis, Inc. (ACB), The Green Organic Dutchman (TGODF), OrganiGram Holdings, Inc. (OGRMF), and INSYS Therapeutics, Inc. (INSY).

Real Brands, Inc. (RLBD) (Market Cap: $18.271M, Share Price: $0.1380)is launching a CBD beverage called Omega Hemp™ Water.

The company just announced that they have engaged an accounting firm that is registered with the Public Company Accounting Oversight Board (PCAOB) to complete their two-year audit which could make the company desirable to larger investors.

The company could be close to its first production run, meaning there could be major news on the way. The audit on the horizon means this could also be another major event that sends this company to the stratosphere. Now's the time to research RLBD.

____

Aurora Cannabis Inc. (ACB) (Market Cap: $7.93B, Share Price: $8.04). The company has a production capacity of roughly 150,000 kilograms of cannabis per year. That number is expected to more than triple to 500,000 by mid-2020. Investors have been buoyed by the company's recent report of revenue rising to $29.9 million in the second quarter to Dec. 29, up 40% from the prior quarter. Proforma revenue, which includes revenue from pending acquisitions, came to $49.5 million.

____

The Green Organic Dutchman (TGODF)(Market Cap: $758.931M, Share Price: $2.87) is a Canadian Licensed Producer growing out of Quebec. According to their investor information, they currently are growing on 620,000 square feet and are expanding to reach 970,000 square feet. Their website also states that they can produce 116,000 kg of cannabis per year. The company just announced that the Danish Medicines Agency, the Government body responsible for issuing cannabis related licenses, has granted an initial cannabis business authorization to TGODF's joint venture production partner Knud Jepsen. This licence will allow TGOD's JV partner Kund Jepsen to immediately begin importation of starting materials and to begin research and development related to the creation of elite cannabis genetics.

____

OrganiGram Holdings, Inc. (OGRMF) (Market Cap: $763.129M, Share Price: $5.93), a cannabis producer, just announced they are adding grow rooms which will more than triple target annual production capacity to 113,000 kg once complete.

____

INSYS Therapeutics, Inc. (INSY)(Market Cap: $294.851M, Share Price: $3.97) announced positive results from its dose-finding pharmacokinetic ("PK") study -INS015-18-124 - evaluating proprietary formulation of epinephrine nasal spray for treating anaphylaxis, an acute, life-threatening allergic reaction. Data from the study showed that the candidate has a similar PK profile with Mylan's MYL EpiPen as well as Par Pharmaceuticals' Adrenalin (epinephrine injection).

Legal Disclaimer:

This article was written by Regal Consulting, LLC ("Regal Consulting"). Regal Consulting has agreed to a three-month term consulting agreement with RLBD dated 8/31/18. The agreement calls for $100,000 note issued to Regal Consulting, and 2,500,000 restricted 144 shares of RLBD for three months of service. Regal has elected to convert $73,000 of principal of the $100,000 note into 2,761,872 Restricted 144 shares of RLBD. Regal Consulting has agreed to a twelve- month term consulting agreement with RLBD dated 1/4/2019. The agreement calls for $10,000 in cash and 500,000 shares per month. All payments were made directly by Real Brands, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspecultors.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. RLBD was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.

https://www.regalconsultingllc.com/full legal disclaimer/

Microspeculators.com Full Legal Disclaimer Click Here.

Contact Information:

Company Name: Microcap Speculators
Contact Person: Media Manager
Email: info@microcapspeculators.com
Phone: 1-702-720-6310
Country: United States
Website: https://microcapspeculators.com/

SOURCE: Regal Consulting, LLC



{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company